Remote Monitoring and Virtual Visits

Key Components of Centralized Monitoring Plans – Compliance Checklist

Posted on digi By digi

Centralized monitoring (CM) brings together statistical analytics, medical review, and operational oversight to detect risks across sites and subjects without relying solely on on-site visits. In remote and hybrid trials, CM is the “always-on” layer that watches data streams—randomization logs, eCOA/ePRO feeds, EDC data quality, safety labs, protocol deviations, and even supply/temperature telemetry—to surface early signals. A good plan defines what is monitored, how often, by whom, using which tools, and what triggers action.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Building Statistical Models for Remote Risk Detection

Posted on digi By digi

Remote and hybrid trials generate continuous data flows from EDC, eCOA/ePRO, IRT, laboratory feeds, imaging reads, and even temperature loggers. Statistical models convert this raw stream into actionable signals—identifying sites at risk of non-compliance, data anomalies, protocol divergence, or patient safety concerns before they crystallize into deviations. In a centralized monitoring (CM) context, modeling is not a quest for academic accuracy; it is a risk-control mechanism that must be transparent, proportionate, and auditable. The model’s outputs ultimately drive decisions: conduct a targeted remote SDR/SDV, hold a virtual site meeting, trigger retraining, or escalate to a for-cause visit. Therefore, the model has to be explainable and traceable, with thresholds that a monitor, a PI, and an inspector can understand.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Comparing Centralized and On-Site Monitoring: Effectiveness and Regulatory Expectations

Posted on digi By digi

Clinical trial oversight has traditionally relied on extensive on-site monitoring to ensure protocol compliance, data accuracy, and subject safety. However, the growing complexity of global trials, budgetary pressures, and digital transformation have catalyzed a shift toward centralized monitoring. This model involves the remote review of clinical trial data using statistical tools, data analytics, and centralized teams rather than relying solely on site visits.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Developing SOPs for Centralized Monitoring Activities

Posted on digi By digi

Standard Operating Procedures (SOPs) form the backbone of quality and compliance in clinical trial monitoring—especially when oversight is conducted remotely through centralized monitoring models. Unlike traditional on-site monitoring where CRA tasks are guided by long-standing templates, centralized monitoring requires new workflows, tools, responsibilities, and decision pathways that must be formally defined, version-controlled, and trained.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Roles and Responsibilities in Centralized Monitoring Teams

Posted on digi By digi

Centralized monitoring has transformed the way sponsors and CROs oversee clinical trials, especially in decentralized and hybrid study models. With digital data flows replacing paper-based visits, the nature of monitoring has shifted from site-focused source document verification to system-wide data pattern analysis. This shift requires rethinking how monitoring teams are structured—and who does what.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Designing Effective Dashboards for Centralized Monitoring

Posted on digi By digi

Centralized monitoring in clinical trials relies on near real-time access to clinical and operational data across all sites. Dashboards serve as the control center of this approach—aggregating data from EDC, ePRO, IRT, labs, and more to visually represent risks, trends, and deviations. A well-designed dashboard is not simply a data visualization tool—it is a regulated oversight mechanism subject to audit and quality control.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Measuring the Effectiveness of Centralized Monitoring

Posted on digi By digi

Centralized monitoring has become a key component of risk-based monitoring (RBM) frameworks in clinical trials. By shifting oversight from routine site visits to remote, analytics-driven review, it promises greater efficiency, improved data quality, earlier issue detection, and enhanced regulatory compliance. But how can sponsors and CROs demonstrate that centralized monitoring actually works?
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Audit Findings Related to Centralized Monitoring Activities

Posted on digi By digi

As remote and hybrid trial models become the norm, centralized monitoring is no longer an experimental oversight technique—it is a regulatory expectation. ICH E6(R2) and the evolving ICH E6(R3) framework both support centralized methods as part of risk-based monitoring (RBM), but they also hold sponsors accountable for validating, documenting, and governing these methods appropriately. Regulators expect clear SOPs, role definitions, audit trails, and documentation in the Trial Master File (TMF) to support centralized oversight activities.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Training Requirements for Centralized Monitoring Teams

Posted on digi By digi

Centralized monitoring has redefined how sponsors oversee clinical trials. As teams shift from site-based monitoring to remote analytics-driven oversight, the skills, workflows, and technologies involved have also changed. This evolution demands a comprehensive training framework tailored to the roles and responsibilities unique to centralized monitoring.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits

Future Trends in Centralized Monitoring and Emerging Technologies

Posted on digi By digi

Centralized monitoring has emerged as a foundational component of risk-based monitoring (RBM) strategies in modern clinical trials. Initially implemented as rule-based dashboards tracking key risk indicators (KRIs) and quality tolerance limits (QTLs), centralized monitoring is rapidly evolving into a more dynamic, predictive, and automated system. This evolution is driven by new data sources, technologies like artificial intelligence (AI), and growing regulatory openness to digital oversight models.
Click to read the full article.

Centralized Monitoring Techniques, Remote Monitoring and Virtual Visits